glp-1 migraine drugs used for diabetes may slash frequency by half GLP-1 medications have become one

[DOI] [PubMed] [Google Scholar] 92.Mesaros A, Koralov SB, Rother E, Wunderlich FT, Ernst MB, Barsh GS, et al

Are There Side Effects You Should Know About

But more research is needed in humans

For example, in the above studies, persistence rates were greater with dulaglutide once weekly compared with exenatide once weekly and liraglutide once daily (5357)

It does not compete directly on maximum weight loss with injectable multi-receptor agonists but instead offers a differentiated value proposition based on oral convenience, no restrictions, lower manufacturing costs, and the potential to dramatically expand the addressable patient population for GLP-1 therapy

Regardless of pathway, GLP-1 medications require evaluation and monitoring by licensed healthcare providers